James Rolke
CIK 1693858 · Chief Executive Officer · last filed 2026-05-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.0K
Companies
2
Total Filings
50
Lifetime Open-Market Net
$31.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| REVBW | Chief Executive Officer | 214,738 | $0.01 | $2.0K | $0 | 6 | 2026-05-01 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Chief Scientific Officer | 81,771 | $6.22 | $508.6K | $31.7K | 44 | 2020-06-02 |
Recent Filings · Page 4 of 5
50 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-02 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +116 | $793 | EDGAR |
| 2019-04-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +131 | $798 | EDGAR |
| 2019-04-02 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +146 | $799 | EDGAR |
| 2019-03-19 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +122 | $792 | EDGAR |
| 2019-03-04 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +164 | $795 | EDGAR |
| 2019-02-19 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +151 | $800 | EDGAR |
| 2019-02-04 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +155 | $795 | EDGAR |
| 2019-01-25 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +792 | $4.5K | EDGAR |
| 2019-01-09 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Buy (P) | +1,600 | $9.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.